Genetically supported causality between gut microbiota, immune cells and morphine tolerance: a two-sample Mendelian

Shuai Han1,2, Jiapei Gao2, Zi Wang1,2

  • 1Department of Anesthesiology, Northern Jiangsu People's Hospital, Clinical Medical School, Yangzhou University, Yangzhou, China.

Frontiers in Microbiology
|February 23, 2024
PubMed
Abstract

Insights

This study used Mendelian randomization to investigate the causal link between gut microbiota, immune cells, and morphine tolerance (MT). Certain gut bacteria and immune cells were found to influence MT risk, suggesting potential therapeutic targets.

Area of Science:

  • Genetics
  • Immunology
  • Microbiology

Background:

  • Previous research suggests a link between gut microbiota/immune cells and morphine tolerance (MT).
  • The causal relationship between these factors and MT remains uncertain.
  • Investigating this association is crucial for understanding MT development.

Purpose of the Study:

  • To investigate the causal association between gut microbiota/immune cells and morphine tolerance (MT).
  • To reveal the impact of gut microbiota/immune cells on the risk of developing MT.
  • To utilize a two-sample Mendelian randomization (MR) study for causal inference.

Main Methods:

  • Employed two-sample Mendelian randomization (MR) using genome-wide association study (GWAS) summary statistics.
  • Utilized inverse variance-weighted (IVW) method as the primary analysis approach.
  • Applied MR-PRESSO, MR-Egger regression, Cochran's Q-test, and leave-one-out analysis to ensure robustness and assess pleiotropy and heterogeneity.

Main Results:

  • Identified 6 gut microbial taxa and 16 immune cells causally related to MT.
  • Found 2 bacterial features and 9 immunophenotypes associated with a lower risk of MT.
  • Detected 4 bacterial features and 7 immunophenotypes significantly associated with an increased MT risk.
  • Confirmed robustness of findings through heterogeneity, pleiotropy, and sensitivity analyses.

Conclusions:

  • Confirmed a potential causal link between gut microbiota, immune cells, and MT.
  • Elucidated potential mechanisms by which gut microbiota and immune cells contribute to MT.
  • Provided a foundation for developing targeted prevention strategies for MT.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
623
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
250
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
199
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
820
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
274
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
476